Global Peanut Allergy Report 2018: API Manufacturers, Marketed and Phase III Drugs Landscape to 2020
Dublin, Sept. 07, 2018 (GLOBE NEWSWIRE) -- The "Peanut Allergy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
Peanut Allergy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018' report provides comprehensive insights about marketed and Phase III products for Peanut Allergy. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country.
Coverage of API manufacturers for Peanut Allergy marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' name along with their location.
This report provides a comprehensive understanding of the emerging Phase III therapies for Peanut Allergy which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.
Key Topics Covered:
1. Report Introduction
2. Peanut Allergy: Overview
- Risk Factors
- Causes
- Symptoms
- Pathophysiology
- Prognosis
- Diagnosis
- Treatment
3. Comparative Analysis of Marketed and Emerging Products
4. Marketed Therapies
- Product Description
- Route of Synthesis
- Mechanism of Action
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Adverse Reactions
- Clinical Trials
- Regulatory Milestones
- Product Development Activities
5. Emerging Therapies (Phase III)
- Product Description
- Research and Development
- Product Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/x27hsf/global_peanut?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Allergy Drugs
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
